Latin America Oil & Gas Q4 2019
Expansion of medicine lists in Latin America will improve commercial returns for drugmakers, especially manufacturersof generic drugs. The financial sustainability of these schemes can be questionable, so firms should expect further government-imposed medicine price cuts. Insufficient investment in healthcare infrastructure and the slow pace of consolidation of medicalservice bureaucracy will impair pharmaceutical market growth in Latin America.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook